Repository logo
 
Publication

Susceptibility to biofilm formation by clinical isolates from patients with urinary tract infection: development of a multifactorial predictive model

2013Conference object Open access
Simple item page
dc.contributor.authorAlves, Maria José
dc.contributor.authorBarreira, João C.M.
dc.contributor.authorFerreira, Isabel C.F.R.
dc.contributor.authorMartins, Anabela
dc.contributor.authorPintado, Manuela
dc.date.accessioned2014-05-12T10:39:20Z
dc.date.available2014-05-12T10:39:20Z
dc.date.issued2013
dc.description.abstractImplantable medical devices help enhancing therapeutic results, saving human lives and improving life quality of patients. However, these devices can be readily colonized by bacteria and fungi, since the presence of a foreign body will reduce the number of microorganisms necessary to produce an infection (Guggenbichler et al., 2011). Accordingly, the aim of this study was to evaluate a group of biofilm producing bacteria isolated from patients with urinary tract infections, identifying the main factors contributing to biofilm formation. It was also intended to evaluate the association of these factors with biofilm formation, in order to understand their contribution as predictors for biofilm onset, allowing an earlier and more effective selection of the required antibiotic treatment. Biofilm detection was done by the tube adherence method. The investigation of the biofilm production was performed measuring its adherence to borosilicate test tubes following a previous methodology (Christensen et al., 1985) with minor changes. Among the 156 isolates, 58 (37.2%) were biofilm producers. The patient’s genre (p=0.022), together with bacterial species (p <0.001), were the factors with highest influence for biofilm production. In fact, some of the isolated bacteria were biofilm producer in all cases. The assayed factors (age, gender, hospital unit, bacteria and catheterization) were used to build a predictive model in order to anticipate biofilm occurrence immediately after bacterial identification. In this way, it is possible to select a more effective antibiotic (among the susceptibility options suggested by the antibiogram) against biofilm producing bacteria, avoiding the need to change antibiotics due to acquired resistance during the treatment. Regarding resistance profile among bacterial isolates, the β-lactamic antibiotics presented the highest cases/percentages: ampicillin (32/55.2%), cephalothin (30/ 51.7%), amoxicillin/clavulanic acid (22/37.9%), although the carbapenemic group still represent a good therapeutic option (2/3.4%). Quinolones (nucleic acid synthesis inhibitors) also showed high resistance percentages. Furthermore, biofilm production clearly increases bacterial resistance. Actually, almost half of biofilm producing bacteria showed resistance against at least three different species.por
dc.identifier.citationAlves, Maria José; Barreira, João C.M.; Ferreira, Isabel C.F.R.; Martins, Anabela; Pintado, Manuela (2013). Susceptibility to biofilm formation by clinical isolates from patients with urinary tract infection: development of a multifactorial predictive model. In Microbiotec’2013. Portuguese Congress of Microbiology and Biotechnology. Aveiropor
dc.identifier.urihttp://hdl.handle.net/10198/9485
dc.language.isoengpor
dc.peerreviewedyespor
dc.relationPortuguese Wild Mushrooms: Chemical characterization and functional study of antiproliferative and proapoptotic properties in cancer cell lines
dc.titleSusceptibility to biofilm formation by clinical isolates from patients with urinary tract infection: development of a multifactorial predictive modelpor
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitlePortuguese Wild Mushrooms: Chemical characterization and functional study of antiproliferative and proapoptotic properties in cancer cell lines
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876-PPCDTI/PTDC%2FAGR-ALI%2F110062%2F2009/PT
oaire.citation.conferencePlaceAveiro, Portugalpor
oaire.citation.titleMicrobiotec’2013. Portuguese Congress of Microbiology and Biotechnologypor
oaire.fundingStream5876-PPCDTI
person.familyNameAlves
person.familyNameBarreira
person.familyNameFerreira
person.familyNameMartins
person.givenNameMaria José
person.givenNameJoão C.M.
person.givenNameIsabel C.F.R.
person.givenNameAnabela
person.identifier144781
person.identifier.ciencia-idD618-B3A9-D312
person.identifier.ciencia-id9418-CF95-9919
person.identifier.ciencia-id7B18-A810-6B93
person.identifier.orcid0000-0001-8506-4393
person.identifier.orcid0000-0003-1233-0990
person.identifier.orcid0000-0003-4910-4882
person.identifier.orcid0000-0001-6218-4413
person.identifier.ridM-6624-2016
person.identifier.ridD-8269-2013
person.identifier.ridE-8500-2013
person.identifier.ridG-5488-2013
person.identifier.scopus-author-id16400584800
person.identifier.scopus-author-id54895546900
person.identifier.scopus-author-id36868826600
person.identifier.scopus-author-id7203013518
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspor
rcaap.typeconferenceObjectpor
relation.isAuthorOfPublication7850f8c2-8834-4d5a-b4a7-df482abd76d3
relation.isAuthorOfPublication4629b12c-39b0-4da8-8b8d-6efba5cf2d81
relation.isAuthorOfPublicationbd0d1537-2e03-41fb-b27a-140af9c35db8
relation.isAuthorOfPublication383370dd-10e5-40e6-9a15-f2201fe95581
relation.isAuthorOfPublication.latestForDiscovery7850f8c2-8834-4d5a-b4a7-df482abd76d3
relation.isProjectOfPublication59db4b60-8cc2-4f07-a25a-8cfe78f2778f
relation.isProjectOfPublication.latestForDiscovery59db4b60-8cc2-4f07-a25a-8cfe78f2778f

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Poster Nac. 159.pdf
Size:
299.56 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.73 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

CIMO - Resumos em Proceedings Não Indexados à WoS/Scopus